Results 281 to 290 of about 10,599,387 (354)

Hemolytic disease of the fetus and newborn due to multiple maternal antibodies

American Journal of Obstetrics and Gynecology, 2015
Karen Q Rossi, Haikady N Nagaraja
exaly   +2 more sources

Hemolytic Disease of the Fetus and Newborn: Historical and Current State.

Clinics in Laboratory Medicine, 2021
Hemolytic disease of the fetus and newborn (HDFN) is an immune-mediated disorder affecting neonates globally, with a range of clinical presentations from severe and life threatening to mild or even asymptomatic.
M. Jackson, J. Baker
semanticscholar   +1 more source

Red blood cell alloimmunization prevalence and hemolytic disease of the fetus and newborn in Israel: A retrospective study

Transfusion, 2020
Hemolytic disease of the fetus and newborn (HDFN) is a severe form of anemia caused by maternal antibodies against fetal red blood cells (RBC) that can cause intrauterine and perinatal morbidity and mortality.
N. Rahimi-Levene, J. Chezar, V. Yahalom
semanticscholar   +1 more source

Identification of red blood cell antibodies in maternal breast milk implicated in prolonged hemolytic disease of the fetus and newborn

Transfusion, 2019
Alloantibodies against more than 50 non‐ABO blood group antigens have been implicated in hemolytic disease of the fetus and newborn (HDFN) and are expected to wane within weeks after delivery.
Alexis Leonard, Lauren Hittson Boal, Philippe P. Pary, Y. Mo, C. Jacquot, N. Luban, D. Darbari, J. Webb   +7 more
semanticscholar   +1 more source

Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non‐D and non‐K‐alloimmunized pregnancies

Transfusion, 2019
Pregnant women are routinely screened for red blood cell (RBC) antibodies early in pregnancy. If RBC‐alloantibodies are detected, repeated laboratory testing is advised to timely identify pregnancies at high risk for severe hemolytic disease of the fetus
J. Koelewijn, Y. Slootweg, C. Folman, I. V. Van Kamp, D. Oepkes, M. de Haas   +5 more
semanticscholar   +1 more source

Severe ABO Hemolytic Disease of the Newborn Requiring Exchange Transfusion

Journal of pediatric hematology/oncology, 2019
ABO incompatibility (ABOi), the most common cause of hemolytic disease of the newborn (HDN), is nearly always mild and treatable with phototherapy. Reports of ABOi HDN requiring neonatal exchange transfusion are extremely rare since the inception of ...
R. Metcalf, J. Khan, J. Andrews, D. Mayock, Zeenia C. Billimoria, M. Pagano   +5 more
semanticscholar   +1 more source

Hemolytic Anemia in Wilson's Disease

New England Journal of Medicine, 1967
JAUNDICE is a common presentation of Wilson's disease and may precede the neurologic features by many years.1 , 2 Infective hepatitis is often invoked as an explanation of the initial episode, and Wilson's disease is rarely considered at that time. Subsequently, neurologic symptoms may lead to a correct diagnosis when such features as jaundice and ...
N, McIntyre, H M, Clink, A J, Levi, J N, Cumings, S, Sherlock   +4 more
openaire   +2 more sources

Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.

New England Journal of Medicine
BACKGROUND In early-onset severe hemolytic disease of the fetus and newborn (HDFN), transplacental transfer of maternal antierythrocyte IgG alloantibodies causes fetal anemia that leads to the use of high-risk intrauterine transfusions in order to avoid ...
K. Moise, Leona E. Ling, D. Oepkes, E. Tiblad, E. Verweij, Enrico Lopriore, J. Smoleniec, U. J. Sachs, G. Bein, M. Kilby, Russell S Miller, R. Devlieger, F. Audibert, S. Emery, K. Markham, Mary E. Norton, O. Ocón-Hernández, Pranav Pandya, L. Pereira, R. M. Silver, R. Windrim, J. B. Streisand, J. H. Leu, A. Mirza, V. Smith, L. Schwartz, M. Tjoa, S. Saeed-Khawaja, Y. Komatsu, J. B. Bussel   +29 more
semanticscholar   +1 more source

Haptoglobin and Hemolytic Disease

JAMA: The Journal of the American Medical Association, 1981
To the Editor.— The article by Marchand et al (1980;243:1909) provides too much hope for a resurrection of haptoglobin determinations as a reliable indicator of hemolytic diseases. First, the introduction of any new or renewed diagnostic measurement should be based on a reliable diagnosis.
openaire   +2 more sources